Simplifying Global Compliance
FDAnews Device Daily Bulletin
Implantable Device Reduces Seizures in Epileptic Patients
Feb. 19, 2013
A medical device company recently received funding from a branch of the NIH to conduct a new two-phase clinical trial for an internally-implanted electronic device that may help treat epilepsy. NeuroSigma, the company behind the device, is basing the new trial on evidence of a similar device, an electronic patch that has been shown to reduce symptoms of depression by up to 50 percent.
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing